oc000162
10.3205/oc000162
urn:nbn:de:0183-oc0001629
Case Report
Outcome of a penetrating keratoplasty in a 3-month-old child with sclerocornea
Pohlmann
Pohlmann
Dominika
D
Dr.
MD
Department of Ophthalmology, Charité – Universitätsmedizin Berlin, Campus Virchow, Augustenburger Platz 1, 13353 Berlin, Germany, Phone: +49 30 450 554202, Fax: +49 30 450 554900Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
dominika.pohlmann@charite.de
author
Rossel
Rossel
Mirjam
M
MD
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
author
Salchow
Salchow
Daniel J.
DJ
MD
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
author
Bertelmann
Bertelmann
Eckart
E
MD
Department of Ophthalmology, Charité – Universitätsmedizin Berlin, Campus Virchow, Augustenburger Platz 1, 13353 Berlin, Germany, Phone: +49 30 450 554202, Fax: +49 30 450 554900Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
eckart.bertelmann@charite.de
author
German Medical Science GMS Publishing House
Düsseldorf
610
congenital corneal opacity
graft survival
pediatric keratoplasty
sclerocornea
20200807
engl
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).
2193-1496
10
GMS Ophthalmology Cases
GMS Ophthalmol Cases
35
Sclerocornea is a rare congenital anomaly with clouding of the peripheral cornea that possibly extends up to the center of the cornea. Characteristically, a clear distinction (limbus) between sclera and cornea is lacking. Early surgical treatment is essential for preventing amblyopia, but penetrating keratoplasty in children carries a relatively high risk of complications. Especially for sclerocornea, penetrating keratoplasty has generally been reported to have a poor surgical outcome and a high risk of complications, including corneoscleral adhesions. Here, we report the 4-year follow-up on a child with sclerocornea, who was successfully operated on at the age of 3 months and had a favorable outcome. Our findings suggest that in some cases, penetrating keratoplasty may be an option to treat sclerocornea in young children.
Introduction<![CDATA[A congenital corneal opacity occurs in 3 of 100,000 n</PlainText></TextGroup>ewborns <TextLink reference="1"></TextLink> and may cause visual impairment and even blindness. In children, deprivation amblyopia may occur if a visually significant corneal opacity is not treated early on. A first report of a penetrating keratoplasty (PK) in a 9-month-old infant with sclerocornea was published in 1970 <TextLink reference="2"></TextLink>. Still, PK in children is considered to carry a high risk for complications <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>, <TextLink reference="4"></TextLink>, <TextLink reference="5"></TextLink>, <TextLink reference="6"></TextLink>, <TextLink reference="7"></TextLink>, <TextLink reference="8"></TextLink>, and PK in sclerocornea is not recommended by some surgeons because of possible catastrophic results including iridocorneal adhesions and graft failure <TextLink reference="2"></TextLink>, <TextLink reference="9"></TextLink>. The surgery is technically challenging in infants due to the elasticity of sclera and cornea, the shallow anterior chamber, anterior displacement of the lens-iris diaphragm, and the smaller size of the eye <TextLink reference="10"></TextLink>. Difficult postoperative examinations and postoperative care contribute to a poor outcome compared to PK in adults. Postoperative complications include suture loosening, corneal infiltrates, and higher rates of graft failure <TextLink reference="3"></TextLink>, <TextLink reference="6"></TextLink>, <TextLink reference="7"></TextLink>, <TextLink reference="10"></TextLink>, <TextLink reference="11"></TextLink>, <TextLink reference="12"></TextLink>. Repeated examinations under anesthesia may be required for postoperative management. Zhang et al. suggest that the main determinants for the outcome of PK in children include indication and types of surgery performed <TextLink reference="10"></TextLink>. In their study conducted in Beijing, the most common indication for PK in children younger than 1<TextGroup><PlainText>2 y</PlainText></TextGroup>ears was congenital corneal opacity which was not further specified. In the same study, the graft survival was 68.1% with a mean follow-up of 33.7 months in infants and children <TextLink reference="10"></TextLink>. Graft failure occurred in 26 eyes of 7<TextGroup><PlainText>9 (2</PlainText></TextGroup>6.6%) in infants aged ≥3 months to 4 years <TextLink reference="10"></TextLink>. Lin et al.’s study on children with congenital corneal opacities found that most eyes with clear grafts achieved ambulatory vision (≥20/960), especially children with bilateral opacity <TextLink reference="13"></TextLink>. Of all surgical indications for PK in children, unilateral sclerocornea was associated with the worst visual outcome. Lin et al. proposed that sclerocornea might be associated with denser opacification and anterior segment dysplasia <TextLink reference="13"></TextLink>; and average graft survival after PK for sclerocornea has been reported to be 36.<TextGroup><PlainText>4 m</PlainText></TextGroup>onths for children under 5 years <TextLink reference="9"></TextLink>. Despite the concern connected with performing PK at an early stage, it may be considered and of value in select patients.</Pgraph><Pgraph>We report our case of a 3-month-old child with bilateral sclerocornea with 4-year follow-up after PK. </Pgraph></TextBlock>
<TextBlock linked="yes" name="Case description">
<MainHeadline>Case description</MainHeadline><Pgraph>A 3-month-old girl presented in March 2015 with bilateral dense corneal opacity since birth. The family history was positive for anterior segmental mesenchymal dysgenesis. Her brother was born in 2019 and also showed corneal opacity, but only in one eye. The mother had a congenital cataract associated with a PITX3 gene mutation; the father had no pertinent ocular history. The children were not genetically examined.</Pgraph><Pgraph>At the first presentation, the girl showed dense corneal opacity and limbal vascularization on both eyes. The opaque corneas of the girl precluded examination of deeper anterior segment structures (Figure 1A, B <ImgLink imgNo="1" imgType="figure"/>). H<TextGroup><PlainText>orizonta</PlainText></TextGroup>l corneal diameter was 10 mm bilaterally, vertical corneal diameter was 9 mm on the right eye (R) an<TextGroup><PlainText>d 8.5 m</PlainText></TextGroup>m on the left eye (L). Axial length was 17.2<TextGroup><PlainText>8 mm (</PlainText></TextGroup>R) and 17.55 mm (L), anterior chamber depth was 2.05 mm (R) and 1.99 mm (L). The retina was a<TextGroup><PlainText>ttach</PlainText></TextGroup>ed on B-scan ultrasound in both eyes. The girl did not fixate or follow objects, and a conjugate horizontal pendular nystagmus as well as esotropia on the left eye were noted. Intraocular pressure (IOP) was normal (<TextGroup><PlainText>R 7.8 mm H</PlainText></TextGroup>g, L 16.5 mm Hg by Schiötz tonometry).</Pgraph><Pgraph>A PK was performed on the left eye in April 2015 and on the right eye in September 2015 by an experienced corneal specialist (EB). Each trepanation of cornea of the recipient was 5.5 mm and each corneal transplant amounted to 6.0 mm with an endothelial cell density of ≥2500 cells/mm<Superscript>2</Superscript>, and was obtained from the Eye Bank Berlin, Charité – Universitätsmedizin Berlin. The first donor cornea was grafted with two continuous sutures using 10-0 and 11-0 monofilament nylon sutures (R<TextGroup><PlainText>esorb</PlainText></TextGroup>a<Superscript>®</Superscript>, Nürnberg, Germany) and single sutures using 10-0 monofilament nylon (Resorba<Superscript>®</Superscript>, Nürnberg, Germany) on the left eye. The right eye was grafted with single sutures using 10-0 monofilament nylon sutures (Resorba<Superscript>®</Superscript>, Nürnberg, Germany) from the beginning.</Pgraph><Pgraph>Postoperatively, prednisolone acetate 1% (Pred Forte, Allergan, Irvine, CA, USA) and unpreserved ofloxacin 0.3% (Floxal<Superscript>®</Superscript> EDO<Superscript>®</Superscript>, Bausch & Lomb, Berlin, Germany), both <TextGroup><PlainText>5 t</PlainText></TextGroup>imes daily, were administered until the corneal sutures were removed on the left eye after 5 months, when the second keratoplasty surgery on the right eye was performed. Then, the treatment was changed to Loteprednoletabonat 0.5% (Bausch & Lomb, Berlin, Germany) 2 times a day. An epithelial defect of the left eye was treated with a bandage contact lens for four weeks. An anterior synechia at 4 o’clock and a loose suture were observed in the left eye one month after surgery. They were replaced, and the synechia was lysed with a spatula through a paracentesis. Throughout the postoperative course, the IOP was at a normal level, ranging from 11 to 18 mm Hg (iCare). The girl fixated large objects with her left eye after one month. One month after the second PK, the refractive error was +8.0 –8.0 x 135° (R) and +4.0 sph (L), so that glasses were prescribed. The anterior synechia was still present in the left eye, the lenses were clear, and the fundoscopic examination revealed a normal optic disc with a cup-to-disc ratio of 0.1, and a normal retina bilaterally. It was recommended that the girl wears the glasses and patches the left eye 1 hour a day. Five months after the second surgery on the right eye, all sutures were removed in both eyes. 17 months after surgery, visual acuity (VA) was 0.16 (Cardiff Acuity Test, CAT) on the lef<TextGroup><PlainText>t e</PlainText></TextGroup>ye. A VA for the right eye could not be measured because the occlusion was not tolerated on the left eye. In Apri<TextGroup><PlainText>l 2</PlainText></TextGroup>017, the girl could fixate and follow objects with the right eye; VA of the left eye was 0.4 with CAT. Complete anterior synechia were noted on the right eye, which were lysed surgically. Under general anesthesia, retin<TextGroup><PlainText>oscop</PlainText></TextGroup>y did not yield a sufficient reflex to measure the refractive error. Part-time occlusion of 1 hour a day of the left eye was continued.</Pgraph><Pgraph>Four years after the first operation, VA was 0.03 (LEA Vision Test in 1 meter) on the right eye, and 0.2 (LEA Vision Test in 6 meters) on the left eye. There was a right esotropia. Horizontal corneal diameter was 9 mm (R) and 10 mm (L), vertical corneal diameter was 10.5 mm bilaterally. Axial length was 21.13 mm (R) and 19.04 mm (L). IOP was 15 mm Hg in both eyes (iCare). The clinical presentation revealed well-adapted corneal transplants with a clear central graft in both eyes with otherwise normal anterior and posterior segment findings.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Discussion">
<MainHeadline>Discussion</MainHeadline><Pgraph>Sclerocornea is a primary anomaly of the eye in which the cornea blends with the sclera, having no clear boundary <TextLink reference="14"></TextLink>. In our case, the mother of the child had a mutation in PITX3, a transcription factor containing homeodomain (HD) that causes cataract and anterior segment mesenchymal dysgenesis in several families <TextLink reference="15"></TextLink>, <TextLink reference="16"></TextLink>.</Pgraph><Pgraph>In general, corneal opacity such as Peters anomaly and sclerocornea have been considered as the main indication for PK in young children. However, there seem to be differences in regional clinical practice regarding the use of PK in this age group. The European corneal experts are more conservative and do not recommend PK in sclerocornea due to poor surgical outcomes <TextLink reference="3"></TextLink>, <TextLink reference="4"></TextLink>, <TextLink reference="9"></TextLink>, <TextLink reference="17"></TextLink>, in contrast to, for example, Asian colleagues <TextLink reference="7"></TextLink>, <TextLink reference="10"></TextLink>, <TextLink reference="11"></TextLink>, <TextLink reference="12"></TextLink>, <TextLink reference="13"></TextLink>.</Pgraph><Pgraph>To note, anatomic success after PK does not always correlate with visual outcome, because visual improvement depends on accurate optical correction and strict adherence to amblyopia therapy, if necessary <TextLink reference="18"></TextLink>. The diagnosis and surgical treatment of a congenital corneal opacity may be challenging for several reasons. First, examination of the patient may be limited, necessitating an exam under general anesthesia. Glaucoma should be ruled out in any child with corneal opacities. Additional diagnostic modalities such as ultrasound of the anterior and posterior segment and anterior segment optical coherence tomography (OCT) may be required to identify the correct diagnosis. In young children, sclera and cornea are smaller and more elastic, and the anterior chamber is shallower, making watertight closure during a PK more difficult in children compared to adults <TextLink reference="4"></TextLink>, <TextLink reference="10"></TextLink>. Increased vitreous pressure in children may result in protrusion of the iris-lens diaphragm when the globe is open during surgery. Postoperatively, pronounced inflammation may lead to synechiae and elevation of IOP <TextLink reference="4"></TextLink>. However, the main complication is the graft failure, which is more common in children than in adults due to the difficulties of postoperative examinations. The reported graft survival rate varied from 32.6% to 78.6% in children for more than one year follow-up <TextLink reference="12"></TextLink>, <TextLink reference="19"></TextLink>. Lin et al. revealed that in children aged 0 to 7 years, the transparent graft rate of congenital corneal opacities was about 55.6% during the 6- to 82-month follow-up period <TextLink reference="13"></TextLink>. Michaeli et al. reported a graft survival rate of 78% in 38 children wit<TextGroup><PlainText>h c</PlainText></TextGroup>ongenital opacities with a mean follow-up of 40.<TextGroup><PlainText>4 m</PlainText></TextGroup>onths <TextLink reference="19"></TextLink>. A study by Yang et al. demonstrated a graft clarity rate of 56% at 6 months and 44% at <TextGroup><PlainText>3 years aft</PlainText></TextGroup>er PK in Peters anomaly <TextLink reference="20"></TextLink>. A recent study by Zhang et al. showed a graft survival in 68.1%, with a mean follow-up of 33.7 months <TextLink reference="10"></TextLink>.</Pgraph><Pgraph>The main cause of corneal graft failure is irreversible r<TextGroup><PlainText>ejectio</PlainText></TextGroup>n. Zhang et al. accounted a graft rejection in 33.<TextGroup><PlainText>8% o</PlainText></TextGroup>f 160 eyes in infants and children, 52% occurred in regrafted patients <TextLink reference="10"></TextLink>. Kim et al. emphasized that the graft survival largely depended on the type of congenital corneal anomaly <TextLink reference="9"></TextLink>. In their study, 7 out of 8 grafts survived in patients with Peters anomaly, whereas 9 out of 12 failed in patients with sclerocornea <TextLink reference="9"></TextLink>. These results were concordant with previous reports demonstrating a poor outcome of PK in sclerocornea <TextLink reference="21"></TextLink>, <TextLink reference="19"></TextLink>. The difference is that Peters anomaly has a clear cornea in the periphery, whereas sclerocornea has scleral tissue extension and vascularization in the periphery of the cornea. This likely contributes to the poorer outcome of PK in sclerocornea and may be a key factor.</Pgraph><Pgraph>Our case also showed peripheral vascularization of the cornea. Postoperatively, the girl developed many risk factors for a potential rejection, including loosening of sutures, anterior synechiae, and new vascularization of the graft. However, there was no increased inflammation, fibrin reaction, or IOP elevation during the postoperative course. We had to change some loosened sutures, and for this reason, the fixation of the graft in children should be done by interrupted sutures as already recommended <TextLink reference="3"></TextLink>, <TextLink reference="4"></TextLink>.</Pgraph><Pgraph>Age may also be an important key factor regarding graft survival after PK in children. The infant’s immune system is still developing and is modulated in order to coexist with the mother’s immune system in a newborn for <TextGroup><PlainText>3 m</PlainText></TextGroup>onths. While humoral immunity is transferred from the mother, T cell-mediated cellular immunity is being developed by the infant. Regulatory T cells (Tregs) have been described as T suppressor cells with a role of ocular privilege <TextLink reference="22"></TextLink> and tolerance induction <TextLink reference="23"></TextLink>. Two subsets of Tregs, natural Tregs (nTregs, which are developed in the thymus), and inducable Tregs (iTregs, which differentiate from naïve CD4 T cells in the periphery under the influence of particular environmental conditions) have been described. It is known that iTregs can induce tolerance in models of graft versus host disease and solid organ transplantation <TextLink reference="24"></TextLink>. In an animal model, it was shown that subconjunctival application of naïve Tregs supports corneal graft survival in baby rats <TextLink reference="25"></TextLink>. Further studies are needed to examine the immune system in children under 1 year of age after PK.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Conclusion">
<MainHeadline>Conclusion</MainHeadline><Pgraph>In our case report, we presented a successful PK in <TextGroup><PlainText>a 3-m</PlainText></TextGroup>onth-old infant without rejections and a well-d<TextGroup><PlainText>evelope</PlainText></TextGroup>d VA after 4 years. We think that in some individual cases a PK in children with sclerocornea is reasonable to prevent lifelong visual impairment.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Notes">
<MainHeadline>Notes</MainHeadline><SubHeadline>Competing interests</SubHeadline><Pgraph>DP discloses that she has financial relationships with Bayer and Allergan. EB discloses that he has financial relationships with Alcon, Johnson & Johnson, Zeiss, and Human Optics. MR and DJS declare that they have no competing interests.</Pgraph><SubHeadline>Scientist program participation</SubHeadline><Pgraph>DP is participant in the Berlin Institute of Health (BIH) Charité clinician scientist program funded by Charité – Universitätsmedizin Berlin and BIH. </Pgraph></TextBlock>
<References linked="yes">
<Reference refNo="1">
<RefAuthor>Bermejo E</RefAuthor>
<RefAuthor>Martínez-Frías ML</RefAuthor>
<RefTitle>Congenital eye malformations: clinical-epidemiological analysis of 1,124,654 consecutive births in Spain</RefTitle>
<RefYear>1998</RefYear>
<RefJournal>Am J Med Genet</RefJournal>
<RefPage>497-504</RefPage>
<RefTotal>Bermejo E, Martínez-Frías ML. Congenital eye malformations: clinical-epidemiological analysis of 1,124,654 consecutive births in Spain. Am J Med Genet. 1998 Feb;75(5):497-504. DOI: 10.1002/(sici)1096-8628(19980217)75:5<497::aid-ajmg8>3.0.co;2-k</RefTotal>
<RefLink>https://doi.org/10.1002/(sici)1096-8628(19980217)75:5<497::aid-ajmg8>3.0.co;2-k</RefLink>
</Reference>
<Reference refNo="2">
<RefAuthor>Wood TO</RefAuthor>
<RefAuthor>Kaufman HE</RefAuthor>
<RefTitle>Penetrating keratoplasty in an infant with sclerocornea</RefTitle>
<RefYear>1970</RefYear>
<RefJournal>Am J Ophthalmol</RefJournal>
<RefPage>609-13</RefPage>
<RefTotal>Wood TO, Kaufman HE. Penetrating keratoplasty in an infant with sclerocornea. Am J Ophthalmol. 1970 Oct;70(4):609-13. DOI: 10.1016/0002-9394(70)90897-4</RefTotal>
<RefLink>https://doi.org/10.1016/0002-9394(70)90897-4</RefLink>
</Reference>
<Reference refNo="3">
<RefAuthor>Seitz B</RefAuthor>
<RefAuthor>Hager T</RefAuthor>
<RefAuthor>Szentmáry N</RefAuthor>
<RefAuthor>Langenbucher A</RefAuthor>
<RefAuthor>Naumann G</RefAuthor>
<RefTitle>Die perforierende Keratoplastik im Kindesalter – das ewige Dilemma</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>Klin Monbl Augenheilkd</RefJournal>
<RefPage>587-94</RefPage>
<RefTotal>Seitz B, Hager T, Szentmáry N, Langenbucher A, Naumann G. Die perforierende Keratoplastik im Kindesalter – das ewige Dilemma [Keratoplasty in children – still a dilemma]. Klin Monbl Augenheilkd. 2013 Jun;230(6):587-94. DOI: 10.1055/s-0032-1328653</RefTotal>
<RefLink>https://doi.org/10.1055/s-0032-1328653</RefLink>
</Reference>
<Reference refNo="4">
<RefAuthor>Bachmann B</RefAuthor>
<RefAuthor>Avgitidou G</RefAuthor>
<RefAuthor>Siebelmann S</RefAuthor>
<RefAuthor>Cursiefen C</RefAuthor>
<RefTitle>Hornhautchirurgie und Hornhauttransplantation bei Kindern</RefTitle>
<RefYear>2015</RefYear>
<RefJournal>Ophthalmologe</RefJournal>
<RefPage>110-7</RefPage>
<RefTotal>Bachmann B, Avgitidou G, Siebelmann S, Cursiefen C. Hornhautchirurgie und Hornhauttransplantation bei Kindern [Pediatric corneal surgery and corneal transplantation]. Ophthalmologe. 2015 Feb;112(2):110-7. DOI: 10.1007/s00347-014-3053-9</RefTotal>
<RefLink>https://doi.org/10.1007/s00347-014-3053-9</RefLink>
</Reference>
<Reference refNo="5">
<RefAuthor>Karadag R</RefAuthor>
<RefAuthor>Chan TC</RefAuthor>
<RefAuthor>Azari AA</RefAuthor>
<RefAuthor>Nagra PK</RefAuthor>
<RefAuthor>Hammersmith KM</RefAuthor>
<RefAuthor>Rapuano CJ</RefAuthor>
<RefTitle>Survival of Primary Penetrating Keratoplasty in Children</RefTitle>
<RefYear>2016</RefYear>
<RefJournal>Am J Ophthalmol</RefJournal>
<RefPage>95-100</RefPage>
<RefTotal>Karadag R, Chan TC, Azari AA, Nagra PK, Hammersmith KM, Rapuano CJ. Survival of Primary Penetrating Keratoplasty in Children. Am J Ophthalmol. 2016 Nov;171:95-100. DOI: 10.1016/j.ajo.2016.08.031</RefTotal>
<RefLink>https://doi.org/10.1016/j.ajo.2016.08.031</RefLink>
</Reference>
<Reference refNo="6">
<RefAuthor>Kusumesh R</RefAuthor>
<RefAuthor>Vanathi M</RefAuthor>
<RefTitle>Graft rejection in pediatric penetrating keratoplasty: Clinical features and outcomes</RefTitle>
<RefYear>2015</RefYear>
<RefJournal>Oman J Ophthalmol</RefJournal>
<RefPage>33-7</RefPage>
<RefTotal>Kusumesh R, Vanathi M. Graft rejection in pediatric penetrating keratoplasty: Clinical features and outcomes. Oman J Ophthalmol. 2015 Jan-Apr;8(1):33-7. DOI: 10.4103/0974-620X.149862</RefTotal>
<RefLink>https://doi.org/10.4103/0974-620X.149862</RefLink>
</Reference>
<Reference refNo="7">
<RefAuthor>Low JR</RefAuthor>
<RefAuthor>Anshu A</RefAuthor>
<RefAuthor>Tan AC</RefAuthor>
<RefAuthor>Htoon HM</RefAuthor>
<RefAuthor>Tan DT</RefAuthor>
<RefTitle>The outcomes of primary pediatric keratoplasty in Singapore</RefTitle>
<RefYear>2014</RefYear>
<RefJournal>Am J Ophthalmol</RefJournal>
<RefPage>496-502</RefPage>
<RefTotal>Low JR, Anshu A, Tan AC, Htoon HM, Tan DT. The outcomes of primary pediatric keratoplasty in Singapore. Am J Ophthalmol. 2014 Sep;158(3):496-502. DOI: 10.1016/j.ajo.2014.05.020</RefTotal>
<RefLink>https://doi.org/10.1016/j.ajo.2014.05.020</RefLink>
</Reference>
<Reference refNo="8">
<RefAuthor>Limaiem R</RefAuthor>
<RefAuthor>Chebil A</RefAuthor>
<RefAuthor>Baba A</RefAuthor>
<RefAuthor>Ben Youssef N</RefAuthor>
<RefAuthor>Mghaieth F</RefAuthor>
<RefAuthor>El Matri L</RefAuthor>
<RefTitle>Pediatric penetrating keratoplasty: indications and outcomes</RefTitle>
<RefYear>2011</RefYear>
<RefJournal>Transplant Proc</RefJournal>
<RefPage>649-51</RefPage>
<RefTotal>Limaiem R, Chebil A, Baba A, Ben Youssef N, Mghaieth F, El Matri L. Pediatric penetrating keratoplasty: indications and outcomes. Transplant Proc. 2011 Mar;43(2):649-51. DOI: 10.1016/j.transproceed.2011.01.055</RefTotal>
<RefLink>https://doi.org/10.1016/j.transproceed.2011.01.055</RefLink>
</Reference>
<Reference refNo="9">
<RefAuthor>Kim YW</RefAuthor>
<RefAuthor>Choi HJ</RefAuthor>
<RefAuthor>Kim MK</RefAuthor>
<RefAuthor>Wee WR</RefAuthor>
<RefAuthor>Yu YS</RefAuthor>
<RefAuthor>Oh JY</RefAuthor>
<RefTitle>Clinical outcome of penetrating keratoplasty in patients 5 years or younger: peters anomaly versus sclerocornea</RefTitle>
<RefYear>2013</RefYear>
<RefJournal>Cornea</RefJournal>
<RefPage>1432-6</RefPage>
<RefTotal>Kim YW, Choi HJ, Kim MK, Wee WR, Yu YS, Oh JY. Clinical outcome of penetrating keratoplasty in patients 5 years or younger: peters anomaly versus sclerocornea. Cornea. 2013 Nov;32(11):1432-6. DOI: 10.1097/ICO.0b013e31829dd836</RefTotal>
<RefLink>https://doi.org/10.1097/ICO.0b013e31829dd836</RefLink>
</Reference>
<Reference refNo="10">
<RefAuthor>Zhang Y</RefAuthor>
<RefAuthor>Liu Y</RefAuthor>
<RefAuthor>Liang Q</RefAuthor>
<RefAuthor>Miao S</RefAuthor>
<RefAuthor>Lin Q</RefAuthor>
<RefAuthor>Zhang J</RefAuthor>
<RefAuthor>Pan Z</RefAuthor>
<RefAuthor>Lu Q</RefAuthor>
<RefTitle>Indications and Outcomes of Penetrating Keratoplasty in Infants and Children of Beijing, China</RefTitle>
<RefYear>2018</RefYear>
<RefJournal>Cornea</RefJournal>
<RefPage>1243-8</RefPage>
<RefTotal>Zhang Y, Liu Y, Liang Q, Miao S, Lin Q, Zhang J, Pan Z, Lu Q. Indications and Outcomes of Penetrating Keratoplasty in Infants and Children of Beijing, China. Cornea. 2018 Oct;37(10):1243-8. DOI: 10.1097/ICO.0000000000001695</RefTotal>
<RefLink>https://doi.org/10.1097/ICO.0000000000001695</RefLink>
</Reference>
<Reference refNo="11">
<RefAuthor>Medsinge A</RefAuthor>
<RefAuthor>Speedwell L</RefAuthor>
<RefAuthor>Nischal KK</RefAuthor>
<RefTitle>Defining success in infant penetrating keratoplasty for developmental corneal opacities</RefTitle>
<RefYear>2014</RefYear>
<RefJournal>Am Orthopt J</RefJournal>
<RefPage>81-8</RefPage>
<RefTotal>Medsinge A, Speedwell L, Nischal KK. Defining success in infant penetrating keratoplasty for developmental corneal opacities. Am Orthopt J. 2014;64:81-8. DOI: 10.3368/aoj.64.1.81</RefTotal>
<RefLink>https://doi.org/10.3368/aoj.64.1.81</RefLink>
</Reference>
<Reference refNo="12">
<RefAuthor>Zhu AY</RefAuthor>
<RefAuthor>Marquezan MC</RefAuthor>
<RefAuthor>Kraus CL</RefAuthor>
<RefAuthor>Prescott CR</RefAuthor>
<RefTitle>Pediatric Corneal Transplants: Review of Current Practice Patterns</RefTitle>
<RefYear>2018</RefYear>
<RefJournal>Cornea</RefJournal>
<RefPage>973-80</RefPage>
<RefTotal>Zhu AY, Marquezan MC, Kraus CL, Prescott CR. Pediatric Corneal Transplants: Review of Current Practice Patterns. Cornea. 2018 Aug;37(8):973-80. DOI: 10.1097/ICO.0000000000001613</RefTotal>
<RefLink>https://doi.org/10.1097/ICO.0000000000001613</RefLink>
</Reference>
<Reference refNo="13">
<RefAuthor>Lin Q</RefAuthor>
<RefAuthor>Shi W</RefAuthor>
<RefAuthor>Miao S</RefAuthor>
<RefAuthor>Zhang Y</RefAuthor>
<RefAuthor>Li L</RefAuthor>
<RefAuthor>Pan Z</RefAuthor>
<RefTitle>Visual Outcomes and Prognostic Factors of Successful Penetrating Keratoplasty in 0- to 7-Year-Old Children With Congenital Corneal Opacities</RefTitle>
<RefYear>2018</RefYear>
<RefJournal>Cornea</RefJournal>
<RefPage>1237-42</RefPage>
<RefTotal>Lin Q, Shi W, Miao S, Zhang Y, Li L, Pan Z. Visual Outcomes and Prognostic Factors of Successful Penetrating Keratoplasty in 0- to 7-Year-Old Children With Congenital Corneal Opacities. Cornea. 2018 Oct;37(10):1237-42. DOI: 10.1097/ICO.0000000000001689</RefTotal>
<RefLink>https://doi.org/10.1097/ICO.0000000000001689</RefLink>
</Reference>
<Reference refNo="14">
<RefAuthor>Elliott JH</RefAuthor>
<RefAuthor>Feman SS</RefAuthor>
<RefAuthor>O’Day DM</RefAuthor>
<RefAuthor>Garber M</RefAuthor>
<RefTitle>Hereditary sclerocornea</RefTitle>
<RefYear>1985</RefYear>
<RefJournal>Arch Ophthalmol</RefJournal>
<RefPage>676-9</RefPage>
<RefTotal>Elliott JH, Feman SS, O’Day DM, Garber M. Hereditary sclerocornea. Arch Ophthalmol. 1985 May;103(5):676-9. DOI: 10.1001/archopht.1985.01050050068020</RefTotal>
<RefLink>https://doi.org/10.1001/archopht.1985.01050050068020</RefLink>
</Reference>
<Reference refNo="15">
<RefAuthor>Berry V</RefAuthor>
<RefAuthor>Yang Z</RefAuthor>
<RefAuthor>Addison PK</RefAuthor>
<RefAuthor>Francis PJ</RefAuthor>
<RefAuthor>Ionides A</RefAuthor>
<RefAuthor>Karan G</RefAuthor>
<RefAuthor>Jiang L</RefAuthor>
<RefAuthor>Lin W</RefAuthor>
<RefAuthor>Hu J</RefAuthor>
<RefAuthor>Yang R</RefAuthor>
<RefAuthor>Moore A</RefAuthor>
<RefAuthor>Zhang K</RefAuthor>
<RefAuthor>Bhattacharya SS</RefAuthor>
<RefTitle>Recurrent 17 bp duplication in PITX3 is primarily associated with posterior polar cataract (CPP4)</RefTitle>
<RefYear>2004</RefYear>
<RefJournal>J Med Genet</RefJournal>
<RefPage>e109</RefPage>
<RefTotal>Berry V, Yang Z, Addison PK, Francis PJ, Ionides A, Karan G, Jiang L, Lin W, Hu J, Yang R, Moore A, Zhang K, Bhattacharya SS. Recurrent 17 bp duplication in PITX3 is primarily associated with posterior polar cataract (CPP4). J Med Genet. 2004 Aug;41(8):e109. DOI: 10.1136/jmg.2004.020289</RefTotal>
<RefLink>https://doi.org/10.1136/jmg.2004.020289</RefLink>
</Reference>
<Reference refNo="16">
<RefAuthor>Semina EV</RefAuthor>
<RefAuthor>Ferrell RE</RefAuthor>
<RefAuthor>Mintz-Hittner HA</RefAuthor>
<RefAuthor>Bitoun P</RefAuthor>
<RefAuthor>Alward WL</RefAuthor>
<RefAuthor>Reiter RS</RefAuthor>
<RefAuthor>Funkhauser C</RefAuthor>
<RefAuthor>Daack-Hirsch S</RefAuthor>
<RefAuthor>Murray JC</RefAuthor>
<RefTitle>A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD</RefTitle>
<RefYear>1998</RefYear>
<RefJournal>Nat Genet</RefJournal>
<RefPage>167-70</RefPage>
<RefTotal>Semina EV, Ferrell RE, Mintz-Hittner HA, Bitoun P, Alward WL, Reiter RS, Funkhauser C, Daack-Hirsch S, Murray JC. A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD. Nat Genet. 1998 Jun;19(2):167-70. DOI: 10.1038/527</RefTotal>
<RefLink>https://doi.org/10.1038/527</RefLink>
</Reference>
<Reference refNo="17">
<RefAuthor>Kampik A</RefAuthor>
<RefAuthor>Lund OE</RefAuthor>
<RefAuthor>Hälbig W</RefAuthor>
<RefTitle>Perforierende Keratoplastik bei kongenitalen Hornhauttrübungen</RefTitle>
<RefYear>1986</RefYear>
<RefJournal>Klin Monbl Augenheilkd</RefJournal>
<RefPage>188-92</RefPage>
<RefTotal>Kampik A, Lund OE, Hälbig W. Perforierende Keratoplastik bei kongenitalen Hornhauttrübungen [Penetrating keratoplasty in congenital corneal opacities]. Klin Monbl Augenheilkd. 1986 Mar;188(3):188-92. DOI: 10.1055/s-2008-1050611</RefTotal>
<RefLink>https://doi.org/10.1055/s-2008-1050611</RefLink>
</Reference>
<Reference refNo="18">
<RefAuthor>Huang C</RefAuthor>
<RefAuthor>O’Hara M</RefAuthor>
<RefAuthor>Mannis MJ</RefAuthor>
<RefTitle>Primary pediatric keratoplasty: indications and outcomes</RefTitle>
<RefYear>2009</RefYear>
<RefJournal>Cornea</RefJournal>
<RefPage>1003-8</RefPage>
<RefTotal>Huang C, O’Hara M, Mannis MJ. Primary pediatric keratoplasty: indications and outcomes. Cornea. 2009 Oct;28(9):1003-8. DOI: 10.1097/ICO.0b013e3181a186c0</RefTotal>
<RefLink>https://doi.org/10.1097/ICO.0b013e3181a186c0</RefLink>
</Reference>
<Reference refNo="26">
<RefAuthor>Dana MR</RefAuthor>
<RefAuthor>Schaumberg DA</RefAuthor>
<RefAuthor>Moyes AL</RefAuthor>
<RefAuthor>Gomes JA</RefAuthor>
<RefTitle>Corneal transplantation in children with Peters anomaly and mesenchymal dysgenesis. Multicenter Pediatric Keratoplasty Study</RefTitle>
<RefYear>1997</RefYear>
<RefJournal>Ophthalmology</RefJournal>
<RefPage>1580-6</RefPage>
<RefTotal>Dana MR, Schaumberg DA, Moyes AL, Gomes JA. Corneal transplantation in children with Peters anomaly and mesenchymal dysgenesis. Multicenter Pediatric Keratoplasty Study. Ophthalmology. 1997 Oct;104(10):1580-6. DOI: 10.1016/s0161-6420(97)30093-1</RefTotal>
<RefLink>https://doi.org/10.1016/s0161-6420(97)30093-1</RefLink>
</Reference>
<Reference refNo="27">
<RefAuthor>Lowe MT</RefAuthor>
<RefAuthor>Keane MC</RefAuthor>
<RefAuthor>Coster DJ</RefAuthor>
<RefAuthor>Williams KA</RefAuthor>
<RefTitle>The outcome of corneal transplantation in infants, children, and adolescents</RefTitle>
<RefYear>2011</RefYear>
<RefJournal>Ophthalmology</RefJournal>
<RefPage>492-7</RefPage>
<RefTotal>Lowe MT, Keane MC, Coster DJ, Williams KA. The outcome of corneal transplantation in infants, children, and adolescents. Ophthalmology. 2011 Mar;118(3):492-7. DOI: 10.1016/j.ophtha.2010.07.006</RefTotal>
<RefLink>https://doi.org/10.1016/j.ophtha.2010.07.006</RefLink>
</Reference>
<Reference refNo="20">
<RefAuthor>Yang LL</RefAuthor>
<RefAuthor>Lambert SR</RefAuthor>
<RefAuthor>Drews-Botsch C</RefAuthor>
<RefAuthor>Stulting RD</RefAuthor>
<RefTitle>Long-term visual outcome of penetrating keratoplasty in infants and children with Peters anomaly</RefTitle>
<RefYear>2009</RefYear>
<RefJournal>J AAPOS</RefJournal>
<RefPage>175-80</RefPage>
<RefTotal>Yang LL, Lambert SR, Drews-Botsch C, Stulting RD. Long-term visual outcome of penetrating keratoplasty in infants and children with Peters anomaly. J AAPOS. 2009 Apr;13(2):175-80. DOI: 10.1016/j.jaapos.2008.10.007</RefTotal>
<RefLink>https://doi.org/10.1016/j.jaapos.2008.10.007</RefLink>
</Reference>
<Reference refNo="21">
<RefAuthor>Rezende RA</RefAuthor>
<RefAuthor>Uchoa UB</RefAuthor>
<RefAuthor>Uchoa R</RefAuthor>
<RefAuthor>Rapuano CJ</RefAuthor>
<RefAuthor>Laibson PR</RefAuthor>
<RefAuthor>Cohen EJ</RefAuthor>
<RefTitle>Congenital corneal opacities in a cornea referral practice</RefTitle>
<RefYear>2004</RefYear>
<RefJournal>Cornea</RefJournal>
<RefPage>565-70</RefPage>
<RefTotal>Rezende RA, Uchoa UB, Uchoa R, Rapuano CJ, Laibson PR, Cohen EJ. Congenital corneal opacities in a cornea referral practice. Cornea. 2004 Aug;23(6):565-70. DOI: 10.1097/01.ico.0000126317.90271.d8</RefTotal>
<RefLink>https://doi.org/10.1097/01.ico.0000126317.90271.d8</RefLink>
</Reference>
<Reference refNo="19">
<RefAuthor>Michaeli A</RefAuthor>
<RefAuthor>Markovich A</RefAuthor>
<RefAuthor>Rootman DS</RefAuthor>
<RefTitle>Corneal transplants for the treatment of congenital corneal opacities</RefTitle>
<RefYear>2005</RefYear>
<RefJournal>J Pediatr Ophthalmol Strabismus</RefJournal>
<RefPage>34-44</RefPage>
<RefTotal>Michaeli A, Markovich A, Rootman DS. Corneal transplants for the treatment of congenital corneal opacities. J Pediatr Ophthalmol Strabismus. 2005 Jan-Feb;42(1):34-44.</RefTotal>
</Reference>
<Reference refNo="22">
<RefAuthor>Whittum JA</RefAuthor>
<RefAuthor>McCulley JP</RefAuthor>
<RefAuthor>Niederkorn JY</RefAuthor>
<RefAuthor>Streilein JW</RefAuthor>
<RefTitle>Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus</RefTitle>
<RefYear>1984</RefYear>
<RefJournal>Invest Ophthalmol Vis Sci</RefJournal>
<RefPage>1065-73</RefPage>
<RefTotal>Whittum JA, McCulley JP, Niederkorn JY, Streilein JW. Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus. Invest Ophthalmol Vis Sci. 1984 Sep;25(9):1065-73.</RefTotal>
</Reference>
<Reference refNo="23">
<RefAuthor>Thurau SR</RefAuthor>
<RefAuthor>Caspi RR</RefAuthor>
<RefAuthor>Chan CC</RefAuthor>
<RefAuthor>Weiner HL</RefAuthor>
<RefAuthor>Nussenblatt RB</RefAuthor>
<RefTitle>Immunologische Suppression der experimentellen Autoimmunuveitis (EAU)</RefTitle>
<RefYear>1991</RefYear>
<RefJournal>Fortschr Ophthalmol</RefJournal>
<RefPage>404-7</RefPage>
<RefTotal>Thurau SR, Caspi RR, Chan CC, Weiner HL, Nussenblatt RB. Immunologische Suppression der experimentellen Autoimmunuveitis (EAU) [Immunologic suppression of experimental autoimmune uveitis]. Fortschr Ophthalmol. 1991;88(4):404-7.</RefTotal>
</Reference>
<Reference refNo="24">
<RefAuthor>Chauhan SK</RefAuthor>
<RefAuthor>Saban DR</RefAuthor>
<RefAuthor>Lee HK</RefAuthor>
<RefAuthor>Dana R</RefAuthor>
<RefTitle>Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation</RefTitle>
<RefYear>2009</RefYear>
<RefJournal>J Immunol</RefJournal>
<RefPage>148-53</RefPage>
<RefTotal>Chauhan SK, Saban DR, Lee HK, Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol. 2009 Jan;182(1):148-53. DOI: 10.4049/jimmunol.182.1.148</RefTotal>
<RefLink>https://doi.org/10.4049/jimmunol.182.1.148</RefLink>
</Reference>
<Reference refNo="25">
<RefAuthor>Hildebrand A</RefAuthor>
<RefAuthor>Jarsch C</RefAuthor>
<RefAuthor>Kern Y</RefAuthor>
<RefAuthor>Böhringer D</RefAuthor>
<RefAuthor>Reinhard T</RefAuthor>
<RefAuthor>Schwartzkopff J</RefAuthor>
<RefTitle>Subconjunctivally applied naïve Tregs support corneal graft survival in baby rats</RefTitle>
<RefYear>2014</RefYear>
<RefJournal>Mol Vis</RefJournal>
<RefPage>1749-57</RefPage>
<RefTotal>Hildebrand A, Jarsch C, Kern Y, Böhringer D, Reinhard T, Schwartzkopff J. Subconjunctivally applied naïve Tregs support corneal graft survival in baby rats. Mol Vis. 2014;20:1749-57.</RefTotal>
</Reference>
</References>
<Media>
<Tables>
<NoOfTables>0</NoOfTables>
</Tables>
<Figures>
<Figure format="png" height="444" width="559">
<MediaNo>1</MediaNo>
<MediaID>1</MediaID>
<Caption><Pgraph><Mark1>Figure 1: Pre- and postoperative stages of penetrating keratoplasty (PK) of the presenting case. The right (A) and left eye (B) revealed a congenital corneal opacity with scleral tissue extension in the center and the periphery of the cornea, and discreet limbal vascularisation. The histological findings confirmed sclerocornea. The corneal grafts were completely clear after PK at 4 days on the right eye (C) and at 5 months on the left eye (D). In the left eye, the sutures had already been removed. After 3 years, both eyes (E, F) showed a clear corneal transplant in the center.</Mark1></Pgraph></Caption>
</Figure>
<NoOfPictures>1</NoOfPictures>
</Figures>
<InlineFigures>
<NoOfPictures>0</NoOfPictures>
</InlineFigures>
<Attachments>
<NoOfAttachments>0</NoOfAttachments>
</Attachments>
</Media>
</OrigData>
</GmsArticle>]]></plaintext></textgroup></pgraph></textblock></origdata></gmsarticle>